Europe Hernia Mesh Devices Market was worth USD 0.94 billion in 2018 and is projected to be growing at a CAGR of 2.8%, to touch 1.07 billion by 2023. The treatment of hernia includes terminating the weak spot present in the muscle through which the intestinal content is distended. Presently, there are two treatment options existing – hernia repair surgeries using sutures, and hernia repair surgeries using mesh. The mending of hernia through surgery using mesh does not create any stress on tissues or muscles; the mesh bridges the gap in the muscle/hernia orifice with few stiches or staples.
Mesh is generally available in various measurements and can often be cut to size. Depending on the repair technique used, the mesh is placed either under or over the defect in the abdominal wall and held in place by a few sutures. Mesh acts as "scaffolding" for new growth of a patient's own tissue, which eventually incorporates the mesh into the surrounding area.
The growth of the Europe Hernia Mesh Devices Market is driven by factors such as increasing incidence of obesity, which is a result of lack of physical activity and an unhealthy diet. Furthermore, excessive physical activity and the growing geriatric population are set to boost market growth in the future. However, strict regulation of product approval, the availability of alternative treatment techniques for hernia damage repair and the high incidences of mesh failure and resulting chronic pains are projected to be the major restraints of market growth.
The Europe Hernia Mesh Devices Market is segmented on the basis of basis of Hernia Type, Product Type and Geography. Based on the Hernia type, the Hernia Mesh Devices market is divided into inguinal, umbilical, hiatal, femoral, incisional, and other types of hernia. Based on Product Type, the Hernia Mesh Devices Market is segmented into synthetic mesh and biologic mesh. The segment of synthetic mesh is further categorised into flat mesh and 3D mesh on the basis of structure of mesh and absorbable, non-absorbable and composite on the basis of absorbance of mesh.
The Europe market has been geographically segmented into Germany, U.K, France, Spain, and Italy. Europe holds the second position in terms of market share globally. There is potential for market growth due to the presence of some untapped markets coupled with the rising frequency of cardiovascular disease incidence. The development of biologic mesh is expected to enhance market growth in the region.
The significant players in the Europe Hernia Mesh Devices Market are Medtronic (U.S.), Ethicon, Inc. (U.S.), C.R. Bard, Inc. (U.S.), Atrium (Sweden), W.L. Gore & Associates (Germany), Lifecell Corporation (U.S.), and B. Braun Melsungen AG (Germany)
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Hernia Type
5.1.1 Introduction
5.1.2 Inguinal
5.1.3 Umbilical
5.1.4 Hiatal
5.1.5 Femoral
5.1.6 Incisional
5.1.7 Others
5.1.5 Y-o-Y Growth Analysis, By Hernia Type
5.1.6 Market Attractiveness Analysis, By Hernia Type
5.1.7 Market Share Analysis, By Hernia Type
5.2 Product Type
5.2.1 Introduction
5.2.2 Synthetic Mesh
5.2.2.1 Mesh Structure
5.2.2.2 Mesh Absorbance
5.2.3 Biological Mesh
5.2.4 Y-o-Y Growth Analysis, By Product Type
5.2.5 Market Attractiveness Analysis, By Product Type
5.2.6 Market Share Analysis, By Product Type
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Hernia Type
6.1.3.3 By Product Type
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Hernia Type
6.1.4.3 By Product Type
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Hernia Type
6.1.5.3 By Product Type
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Medtronic
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 StemCells
8.3 Cryo Cell International
8.4 Geron Corporation
8.5 Mesoblast
8.2 Ethicon
8.3 C R Bard
8.4 Atrium
8.5 W L Gore and Associates
8.6 Lifecell Corporation
8.7 B Braun Melsungen
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
